Strategic Funding Imperative Care has recently secured a substantial $100 million convertible note financing, signaling strong investor confidence and potential expansion capacity for the Telos robotic platform and related care delivery initiatives.

Robotic Platform Telos is positioned as a remote and on-site aspiration thrombectomy solution in collaboration with Proximie, targeting stroke treatment improvements and expanded access to lifesaving care.

Clinical Validation Ongoing and recent clinical activities and trial results, including a next-generation thrombectomy system and pulmonary embolism work, provide a foundation for credibility with hospitals and procurement teams.

Executive Mobility Board and leadership broadenings, with appointments like Evan Melrose to the board and a dedicated CFO, indicate governance and financial discipline favorable for enterprise sales cycles and large hospital contracts.

Market Readiness The company operates in a multi‑vendor health tech ecosystem with a growing emphasis on minimally invasive neurovascular and stroke interventions, aligning Telos with high‑demand specialties and key purchasing committees.